Log in

Rhythm Pharmaceuticals Price Target & Analyst Ratings (NASDAQ:RYTM)

+0.19 (+0.92 %)
(As of 10/13/2019 04:00 PM ET)
Today's Range
Now: $20.87
50-Day Range
MA: $22.07
52-Week Range
Now: $20.87
Volume100,188 shs
Average Volume209,762 shs
Market Capitalization$720.22 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Rhythm Pharmaceuticals in the last 12 months. Their average twelve-month price target is $38.80, suggesting that the stock has a possible upside of 85.91%. The high price target for RYTM is $43.00 and the low price target for RYTM is $34.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $38.80$38.80$38.67$39.40
Price Target Upside: 85.91% upside85.20% upside87.16% upside31.99% upside

Rhythm Pharmaceuticals (NASDAQ:RYTM) Consensus Price Target History

Rhythm Pharmaceuticals (NASDAQ:RYTM) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/25/2019CowenReiterated RatingBuy$40.00High
9/9/2019LADENBURG THALM/SH SHReiterated RatingBuy$43.00Low
7/29/2019Stifel NicolausReiterated RatingBuy$34.00High
7/8/2019Canaccord GenuityInitiated CoverageBuy ➝ Buy$35.00High
5/5/2019Needham & Company LLCReiterated RatingBuy$42.00Low
9/7/2018Morgan StanleyInitiated CoverageOverweightLow
10/30/2017Bank of AmericaInitiated CoverageBuy$30.00N/A
(Data available from 10/13/2017 forward)
This page was last updated on 10/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel